PodcastsCiência políticaFixing Healthcare Podcast

Fixing Healthcare Podcast

Robert Pearl and Jeremy Corr
Fixing Healthcare Podcast
Último episódio

323 episódios

  • Fixing Healthcare Podcast

    FHC #216: An unfiltered look at what legacy means in medicine

    26/05/2026 | 43min
    In this Unfiltered episode of Fixing Healthcare, Drs. Robert Pearl and Jonathan Fisher explore three questions that reach across medicine, leadership and life itself: What legacy do physicians leave behind? How does mindset shape health and longevity? And can doctors still find fulfillment as medical practice shifts from independence to employment?

    The conversation begins with Tim Cook’s legacy at Apple, using his tenure as CEO to ask a larger question about values, mission and compromise. Pearl and Fisher examine whether legacy is something others assign after a career ends or something professionals create daily through their choices, actions and alignment with their deepest values. For physicians, the question becomes especially personal when financial, organizational or career decisions collide with the promise to put patients first.

    Midway through, the discussion turns to longevity and the science of mindset. Drawing on research from Yale and Fisher’s work in Just One Heart, the two physicians explore how beliefs about aging can influence physical function, cognitive health, inflammation and long-term well-being. Fisher explains why optimism is not merely a pleasant attitude but a physiologic force that can shape stress hormones, inflammatory pathways and the daily behaviors that determine health.

    Finally, Pearl and Fisher examine one of the biggest structural shifts in modern medicine: the movement from physician-owned practices to employment by hospitals, health systems and insurers. Fisher notes that independent doctors may report lower burnout, but autonomy is no longer guaranteed when administrative burdens, call schedules and financial pressures consume the practice of medicine. Employment offers support and stability, but often at the cost of control.

    By the end, the episode connects all three themes: legacy, health and professional fulfillment are rooted in purpose. Whether through family, patient care, mission trips, mentoring or the daily work of medicine, Pearl and Fisher suggest that doctors may live longer, healthier and more meaningful lives when they preserve the mission that brought them to medicine in the first place.

    For listeners who connected with Fisher’s reflections on burnout, autonomy and the search for renewed purpose in medicine, his upcoming ASPIRE physician retreat offers a deeper opportunity for reflection and recovery. Co-facilitated with Dr. Robyn Tiger, ASPIRE is a CME-accredited retreat designed exclusively for healthcare professionals, taking place June 12-14 at the Art of Living Retreat Center in Boone, North Carolina. Use code ASPIRE15 for 15% off registration.

    For more unfiltered conversation, listen to the full episode and explore these related resources:

    ‘Just One Heart’ (Jonathan Fisher’s newest book)

    ‘ChatGPT, MD’ (Robert Pearl’s newest book)

    Monthly Musings on American Healthcare (Robert Pearl’s newsletter)

    * * *

    Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple Podcasts, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn.

    The post FHC #216: An unfiltered look at what legacy means in medicine appeared first on Fixing Healthcare.
  • Fixing Healthcare Podcast

    FHC #215: Revisiting healthcare leadership, technology & capitation

    19/05/2026 | 38min
    Fixing Healthcare hosts Jeremy Corr and Dr. Robert Pearl are revisiting a past episode of Diving Deep while Dr. Pearl travels and keynotes events around the world. And like last week’s replay, this conversation was selected for a reason.

    Originally recorded more than three years ago, this episode explores two issues that remain central to the future of American medicine: how healthcare leaders respond to technological change and whether the nation can finally move beyond fee-for-service reimbursement.

    Looking back now, the discussion feels strikingly current. Many of the opportunities Dr. Pearl identified at the time still exist today. Generative AI has advanced dramatically. Remote monitoring tools are more powerful and accessible than ever. And healthcare leaders continue to acknowledge the need for better chronic disease management, prevention and lower-cost care delivery.

    Yet despite these advances, many of the nation’s biggest healthcare problems remain unresolved. U.S. quality outcomes still lag peer nations. Life expectancy remains years shorter than in comparable countries. And healthcare costs continue rising at rates that far exceed inflation, wage growth and GDP.

    Throughout the episode, Dr. Pearl argues that these failures are not primarily technological. The tools to improve care already existed — and continue to improve rapidly today. The greater challenge is leadership itself: helping clinicians embrace change, aligning incentives around patient outcomes and building the operational systems required to make better care possible at scale.

    The conversation also revisits capitation and value-based care, themes that have resurfaced repeatedly in recent Fixing Healthcare episodes. Dr. Pearl explains why fee-for-service reimbursement continues to reward volume over outcomes and why meaningful progress in affordability will require shifting financial incentives toward prevention, chronic disease control and long-term patient health.

    Revisiting this episode now offers a useful perspective on the past several years of healthcare transformation: technology has accelerated, but the deeper structural changes required to improve affordability and outcomes have moved far more slowly.

    Helpful links

    The Anatomy Of Healthcare Leadership: A Mind For Technology (Forbes)

    Healthcare Leadership: Following The Money Can Lead To Positive Change (Forbes)

    Monthly Musings on American Healthcare (RobertPearlMD.com)

    * * *

    Dr. Robert Pearl is the author of “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine.” Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on Twitter and LinkedIn.

    The post FHC #215: Revisiting healthcare leadership, technology & capitation appeared first on Fixing Healthcare.
  • Fixing Healthcare Podcast

    FHC #214: Revisiting GLP-1 prices and ChatGPT’s early leap forward

    12/05/2026 | 35min
    For the next two weeks, Fixing Healthcare hosts Jeremy Corr and Dr. Robert Pearl will be replaying past episodes of Diving Deep while Dr. Pearl travels and keynotes events around the world. But these aren’t random reruns. They were selected for a reason: to highlight just how quickly technology is advancing and how slowly healthcare is adapting.

    This week’s flashback revisits a July 2024 conversation recorded shortly after OpenAI released GPT-4o, a major leap forward in generative AI at the time. Less than two years later, the pace of change is striking. Capabilities that once felt groundbreaking now seem primitive compared to what today’s AI tools can accomplish for patients, physicians and healthcare organizations.

    At the same time, the episode’s broader themes remain remarkably current. Dr. Pearl and Jeremy discuss the future role of generative AI in medicine, how these tools could improve diagnosis and patient monitoring and why healthcare institutions often struggle to embrace transformative technology quickly.

    The episode also examines another issue that remains unresolved today: the high cost of GLP-1 medications like Wegovy and Ozempic. Dr. Pearl explains why these highly effective obesity treatments remain financially out of reach for many Americans despite growing demand and expanding clinical use.

    Revisiting this conversation now offers a useful reminder: technology can advance extraordinarily fast, but healthcare systems, incentives and policies often lag far behind.

    Helpful links: 

    OpenAI’s Rule-Shattering GPT-4o Update Will Be Lifesaving, Too (Forbes)

    Wegovy And Ozempic Are Overpriced By 400-500% — Here’s A Quick Solution (Forbes)

    Monthly Musings on American Healthcare (Robert Pearl’s newsletter)

    * * *

    Dr. Robert Pearl is the author of “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine.” Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn.

    The post FHC #214: Revisiting GLP-1 prices and ChatGPT’s early leap forward appeared first on Fixing Healthcare.
  • Fixing Healthcare Podcast

    FHC #213: Longevity myths, healthcare costs & why medicine must subtract to improve

    05/05/2026 | 38min
    In this Diving Deep episode, Dr. Robert Pearl and Jeremy Corr dissect two issues that are often discussed separately but are deeply intertwined: how Americans can live longer, healthier lives and how the nation can make healthcare more affordable.

    The conversation begins with longevity. As interest in lifespan and “healthspan” grows, Dr. Pearl challenges three widely held beliefs that, in his view, are holding Americans back. First, the idea that physical and cognitive decline is inevitable with age. New research suggests that nearly half of older adults improve over time, particularly when they maintain a positive outlook and stay physically and mentally active. Second, the belief that longevity can be “hacked” through supplements, peptides and other quick fixes. Despite a $50 billion market and widespread adoption, Pearl explains that most of these interventions lack strong clinical evidence in humans. And third, the assumption that prevention can wait until middle age. Updated cardiovascular guidelines show that earlier screening and intervention, particularly around LDL cholesterol, can dramatically reduce long-term risk.

    From there, the discussion shifts to the financial side of healthcare. Pearl argues that improving population health is the most effective way to reduce costs, but that meaningful change will also require a fundamental redesign of how care is delivered. Drawing on behavioral research, he introduces a central concept: healthcare leaders tend to solve problems by adding more resources (staff, beds, technology) when better outcomes often require subtraction first.

    The second half of the episode applies this “subtraction before addition” framework across the healthcare system. In outpatient care, Pearl describes how the traditional small physician office has become increasingly inefficient in an era dominated by chronic disease and administrative complexity. He proposes larger, integrated models that share staff, leverage generative AI and shift from calendar-based visits to continuous, need-based care. In emergency departments, he outlines how segmenting patients by clinical severity could reduce wait times, improve outcomes and lower costs by treating low-risk cases through primary care pathways. And in inpatient settings, he points to hospital-at-home programs as a way to safely care for a significant share of patients at lower cost and with better outcomes.

    Taken together, this episode teaches that Americans can extend both lifespan and healthspan by rejecting outdated assumptions and focusing on proven behaviors. At the same time, healthcare affordability will not improve by continuing to add more of the same. It will require eliminating inefficiencies, redesigning care delivery and replacing outdated models with ones better suited to modern medicine.

    For more, tune into this month’s episode and check out the links below.

    Helpful links

    New Studies Show Americans Are Thinking About Longevity All Wrong (Forbes)

    The More We Add To U.S. Healthcare, The Worse It Gets (Forbes)

    Monthly Musings on American Healthcare (RobertPearlMD.com)

    * * *

    Dr. Robert Pearl is the author of “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine.” Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn.

    The post FHC #213: Longevity myths, healthcare costs & why medicine must subtract to improve appeared first on Fixing Healthcare.
  • Fixing Healthcare Podcast

    MTT #106: Trump’s 2027 budget & the other threats to U.S. healthcare

    29/04/2026 | 41min
    In this week’s episode of Medicine: The Truth, hosts Jeremy Corr and Dr. Robert Pearl probe the facts beneath healthcare biggest headlines. Today’s show features an in-depth look at sweeping federal budget cuts, the expanding (and often misunderstood) impact of GLP-1 medications and what’s destabilizing health coverage.

    The conversation opens with a stark warning. Dr. Pearl reviews the president’s proposed 2027 budget, which includes a $15.8 billion reduction in healthcare spending. He explains why cuts to Medicaid, NIH research and global health programs could have consequences that extend far beyond the next fiscal year, potentially slowing innovation, increasing patient risk and shifting costs to states and families.

    From there, the episode turns to one of the most asked-about topics from listeners: GLP-1 weight-loss drugs. While these medications clearly produce meaningful weight loss and improve outcomes in conditions tied to obesity, Dr. Pearl cautions that many of the broader health claims attributed to them may simply reflect the benefits of weight loss itself, not unique properties of the drugs.

    Throughout the episode, an underlying truth: scientific progress continues but policy decisions, pricing dynamics and system design may limit who benefits (and at what cost).

    Here are the other major storylines from episode 106:

    Federal health cuts threaten long-term progress: The proposed budget reduces overall healthcare funding by 12.5%, cuts NIH support by $5 billion and consolidates public health agencies.

    Global health funding drops sharply: International health spending is being cut nearly in half, while continued withdrawal from the World Health Organization leaves the U.S. more vulnerable to future pandemics.

    CDC leadership signals a policy shift: The nomination of Dr. Erica Schwartz as permanent CDC director suggests a move back toward a more traditional, science-driven approach to vaccines.

    RFK Jr. softens vaccine stance amid political pressure: In congressional testimony, the HHS secretary publicly acknowledged the safety and effectiveness of the measles vaccine.

    GLP-1 drugs deliver clear weight loss and major benefits: Studies show 10-20% weight reduction, along with approximately 20% improvements in kidney and cardiovascular outcomes.

    Many GLP-1 “breakthroughs” may reflect weight loss alone: Evidence linking these drugs to reduced cancer risk, improved cognition or lower addiction rates remains fuzzy at best.

    Exercise rivals the impact of breakthrough drugs: A large study shows vigorous physical activity reduces risks of dementia, diabetes, cardiovascular disease and death at levels comparable to or greater than GLP-1 outcomes.

    Stress does not directly cause cancer: Pearl explains that while many Americans believe stress leads to cancer, the real risk comes from behavioral responses such as increased smoking and alcohol use.

    Concierge medicine expands access for some: Patients who can afford annual fees gain faster access and more time with physicians, but the model reduces availability for others.

    China rapidly closes the drug development gap: New data show China’s share of global pharmaceutical research rising to over 32%, nearly matching the United States.

    Exchange coverage declines and risk pools worsen: Millions may lose insurance due to subsidy changes, premium nonpayment and shifts to high-deductible plans.

    Drug prices continue to rise despite reform efforts: Under the TrumpRx program, lower prices on select drugs have been offset by increases elsewhere, with new medications averaging $353,000 annually.

    Robotics and AI may arrive faster than expected: A dramatic improvement in robot race performance leads Dr. Pearl to revise his estimate for clinical adoption of robotic procedures.

    Tune in for more fact-based analysis and practical perspective on the healthcare policies, technologies and trends shaping medicine today.

    * * *

    Dr. Robert Pearl is the author of “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine” about the impact of AI on the future of medicine.

    Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn.

    The post MTT #106: Trump’s 2027 budget & the other threats to U.S. healthcare appeared first on Fixing Healthcare.
Mais podcasts de Ciência política
Sobre Fixing Healthcare Podcast
“A podcast with a plan to fix healthcare” featuring Dr. Robert Pearl, Jeremy Corr and Guests
Sítio Web de podcast

Ouve Fixing Healthcare Podcast, Economics for Inclusive Prosperity e muitos outros podcasts de todo o mundo com a aplicação radio.pt

Obtenha a aplicação gratuita radio.pt

  • Guardar rádios e podcasts favoritos
  • Transmissão via Wi-Fi ou Bluetooth
  • Carplay & Android Audo compatìvel
  • E ainda mais funções
Fixing Healthcare Podcast: Podcast do grupo